Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06753487

"Effects of Facilitated Positional Release Technique( FPRT) Vs. Manual Myofascial Release Technique in Female Patients With Piriformis Syndrome

"Effects of Facilitated Postional Release Technique( FPRT) Vs Manual Myofascial Release Technique in Female Patients With Piriformis Syndrome

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
38 (estimated)
Sponsor
Foundation University Islamabad · Academic / Other
Sex
Female
Age
25 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This study is a randomised control trial and the purpose of this study is to determine the "Effects of Facilitated Postional Release Technique( FPRT) Vs Manual Myofascial Release Technique in Female Patients With Piriformis Syndrome.

Detailed description

The purpose of this study is to determine the "Effects of Facilitated positional release technique vs manual myofascial release technique in female patietns with piriformis syndrome. we make 2 groups control and treatment group . we give FPRT technique to treatment group and manual release technique to control group in patients with piriformis syndrome. first we take base line readings of HIP ROMS( abduction, adduction, internal rotation, external rotation),NPRS and LEFS(lower extremity functional scale).. after 2 weeks of treatment again we take same readings and compare both readings.

Conditions

Interventions

TypeNameDescription
PROCEDUREMyofacial ReleaseManual Myofascial Release: Control group will receive 3- 5 repetitions of Manual Myofascial Release in Piriformis muscle i.e giving ischemic pressure on muscle directly for 90 secs and then release.
PROCEDUREFacilitated positional release techniqueFPRT: Treatment group will receive 5 repetitions of FACILITATED POSITIONAL RELEASE technique i.e applying pressure over tender area of muscle while maintaining specific postion

Timeline

Start date
2024-07-26
Primary completion
2025-04-01
Completion
2025-04-15
First posted
2024-12-31
Last updated
2024-12-31

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06753487. Inclusion in this directory is not an endorsement.